Corneal Neovascularization - 20 Studies Found
| Completed |
: Bevacizumab for the Treatment of Corneal Neovascularization : Corneal Neovascularization : 2009-10-08 : Drug: Bevacizumab Topical 10 mg/cc or subconjunctival 2.5 mg/0.1cc |
| Completed |
: Treatment of Corneal Neovascularization With Topical Pazopanib : Corneal Neovascularization : 2010-11-22 : Drug: Pazopanib (5mg/ml) Topical pazopanib, 4 times per day for 3 weeks |
| Completed |
: Prospective Study to Determine the Effect of Subconjunctival Bevacizumab (AVASTIN) in Corneal Neovascularization : Corneal Neovascularization : 2007-11-07 : Drug: Bevacizumab (Avastin) One dose of 0.1cc of subconjunctival Bevacizumab was applied |
| Completed |
: The Effect of Bevacizumab on Corneal Neovascularization : Corneal Neovascularization : 2008-11-22 : Drug: Bevacizumab subconjunctival injection of 1.25 mg bevacizumab and had a follow-up of at least 2 mon |
| Not yet recruiting |
: Strategies for Management of Corneal Neovascularisation : Corneal Neovascularisation : 2015-10-27 :
|
| Terminated |
: Topical IL-1-Ra for Treatment of Corneal Neovascularization : Corneal Neovascularization : 2009-06-04 :
|
| Completed |
: Topical Avastin for Treatment of Corneal Neovascularization : Corneal Neovascularization : 2007-11-14 : Drug: Topical Avastin 1% Avastin (bevacizumab) 1% Ot |
| Completed |
: Effectiveness and Safety of Topical Ranibizumab for Treatment of Corneal Neovascularization (NV) : Corneal Neovascularization : 2008-05-19 : Drug: Ranibizumab 10 Patients will receive treatment (Ranibizumab) |
| Completed |
: Effectiveness and Safety of Topical Bevacizumab (Avastin) for Treatment of Corneal Neovascularization : Corneal Neovascularization : 2007-08-06 : Drug: Bevacizumab (Avastin) Bevacizumab 10mg/mL 1 drop BID x 3 weeks |
| Completed |
: Randomized Study of Photodynamic Therapy Using Dihematoporphyrin in Patients With Corneal Neovascularization : Corneal Neovascularization : 1999-10-18 :
|